Traditional Chinese medicine preparation for treating encephaledema and preparation method of traditional Chinese medicine preparation

Abstract

The invention discloses a traditional Chinese medicine preparation for treating encephaledema. The traditional Chinese medicine preparation is prepared from raw materials in parts by weight as follows: 30-40 parts of thunberg fritillary bulb, 30-40 parts of astragalus membranaceus, 10-20 parts of gentiana rhodantha, 20-30 parts of indian bread, 30-40 parts of Chinese angelica, 10-20 parts of prepared rehmannia roots, 20-30 parts of rhizome of broadleaf common valeriana, 20-30 parts of danshen roots, 5-15 parts of medcinal evodia fruit, 10-20 parts of honeysuckle flowers, 10-20 parts of buerger pipewort flowers and 10-20 parts of heterophylly falsestarwort roots. The traditional Chinese medicine preparation for treating encephaledema has the functions of qi supplement, promotion of blood circulation, meridian dredging, diuresis inducing, improvement of brain microcirculation, promotion of attraction of cerebrospinal fluids, anti-inflammatory effect, swelling elimination, adhesion softening, elimination of cerebrospinal fluid circulatory barriers, protection and recovery of nerve cells and the like and can treat hypertensive intracranial syndromes caused by encephaledema and other reasons. The medicine is taken orally for three times a day when used for treatment, about 10 g of the medicine is taken each time, 15 days is counted as a treatment course, and encephaledema can be cured usually after two treatment courses.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine

Login to view more

AI Technical Summary

Benefits of technology

This new type herbal medications used alone could help reduce brain damage during stroke symptoms such as hemorrhage from subarachnoid bleeding (bleedings). These therapies aim to restore normal functioning of neurons that are damaged due to strokes. They also improve their ability to absorb nutrients through stimulating small capillaries called arteriole walls around them.

Problems solved by technology

This patents discusses how treatments involving decompressive bleeding often result from acute conditions like enzyme overload or inflammatory processes leading to accumulation of fluid within cells called peritoneum lining them. Existing methods involve injectable agents, but they may also lead to secondary issues including rejection after therapy. There has been an effort towards developing new ways to provide medicines without these drawbacks while maintaining efficacy against chronic forms of brain swelling.